Caribou Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	145	507	383	908	-
Market Cap Growth	42.62%	32.27%	-57.82%	-	-
Enterprise Value	-122	205	163	532	-14
PE Ratio	-	-4.96	-3.85	-13.57	-
PS Ratio	4.33	14.70	27.66	94.63	-
PB Ratio	0.42	1.38	1.27	2.34	-
P/FCF Ratio	-4.09	-4.83	-3.93	-26.22	-
P/OCF Ratio	-4.53	-5.43	-4.21	-27.93	-
EV/Sales Ratio	5.91	5.95	11.78	55.48	-1.16
EV/EBITDA Ratio	-1.80	-2.13	-1.70	-8.11	0.41
EV/EBIT Ratio	-1.72	-2.01	-1.64	-7.99	0.40
EV/FCF Ratio	-1.74	-1.95	-1.67	-15.37	0.43
Debt / Equity Ratio	0.08	0.07	0.09	-	-0.07
Debt / EBITDA Ratio	-0.25	-0.28	-0.29	-	-0.04
Debt / FCF Ratio	-0.24	-0.26	-0.28	-	-0.05
Quick Ratio	10.22	11.70	8.89	14.81	1.70
Current Ratio	10.49	11.97	9.25	15.15	1.96
Asset Turnover	0.08	0.09	0.03	0.03	0.25
Interest Coverage	-	-	-	-	-1805.35
Return on Equity (ROE)	-33.40%	-31.10%	-29.60%	-37.80%	429.50%
Return on Assets (ROA)	-28.00%	-25.70%	-24.20%	-21.80%	-70.00%
Return on Capital (ROIC)	-35.35%	-29.34%	-32.38%	-17.27%	165.26%
Earnings Yield	-79.76%	-20.14%	-25.95%	-7.37%	-
FCF Yield	-78.60%	-20.70%	-25.43%	-3.81%	-
Buyback Yield / Dilution	-45.95%	-21.39%	-92.02%	-270.47%	-2.05%
Total Shareholder Return	-45.95%	-21.39%	-92.02%	-270.47%	-2.05%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).